Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -Publisher
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10072-023-07210-z
Keywords
Diagnostic yield; Neuromuscular disease; Next-generation sequencing; Exome; Pediatric patients
Categories
Ask authors/readers for more resources
Whole exome sequencing (WES) plays an important role in the diagnosis of pediatric-onset neuromuscular diseases (NMD), helping to determine genetic diagnosis and treatment selection, especially in cases where other technologies have failed or in complex situations.
Diagnosis of neuromuscular diseases (NMD) can be challenging because of the heterogeneity of this group of diseases. This review aimed to describe the diagnostic yield of whole exome sequencing (WES) for pediatric-onset neuromuscular disease diagnosis, as well as other benefits of this approach in patient management since WES can contribute to appropriate treatment selection in NMD patients. WES increases the possibility of reaching a conclusive genetic diagnosis when other technologies have failed and even exploring new genes not previously associated with a specific NMD. Moreover, this strategy can be useful when a dual diagnosis is suspected in complex congenital anomalies and undiagnosed cases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available